What started 30 years ago developed into one of the largest service providers in the field of clinical trials as a laboratory provider supporting clinical trials of phases one to four. Today LKF has more than 130 highly motivated employees working in a wide variety of areas in a highly automated surrounding. LKF will continue to stand for quality, reliability and flexibility in the future.

It is our great pleasure to announce that LKF – Laboratorium für Klinische Forschung GmbH - has reorganized the board of directors with the beginning of the new year: Dr. Gerrit Schoenicke, MD and Dr. Volker El-Samalouti have taken over the role as managing directors and, together with Bärbel Wilke, they will be responsible for the ongoing development of the company. Former managing director Uwe Troge will remain responsible as an authorized signatory.

ABF Pharmaceutical Services has now received the confirmation for the extension of its GMP-certificate from the Austrian health authority (BASG = Bundesamt für Sicherheit und Gesundheitswesen). This means that also our new services, storage at -150 °C of MCBs (Master Cell Banks)/WCBs (Working Cell Banks) and APIs (Active Pharmaceutical Ingredient) have been officially approved. We are very happy about this good news which underlies ABF’s strive for quality and guarantees GMP-compliance operations for our customers.